Panacea Life Sciences HoldingsPLSH +3.64% Pretax Margin % is -368.00% as of Sep. 2025. The stock has 6 warning signs investors should review. Among 955 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks better than 98.74% on this metric.
The historical rank and industry rank for Panacea Life Sciences Holdings's Pretax Margin % or its related term are showing as below:
PLSH'
s Pretax Margin % Range Over the Past 10 Years
Min: -561.95 Med: -284.1 Max: 91.29
Current: 91.29
PLSH's Pretax Margin % is ranked better than 98.74% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs PLSH: 91.29
Panacea Life Sciences Holdings (OTCPK:PLSH) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Panacea Life Sciences Holdings Pretax Margin % Related Terms
Panacea Life Sciences Holdings Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings Pretax Margin % Chart
PLSH vs NPHC, OWPC, CBDY: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings (PLSH) has a Pretax Margin % of -368.00% as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Panacea Life Sciences Holdings and its competitors. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #12 out of 955 companies in the Drug Manufacturers industry, placing it in the top 1.3%.
Is Panacea Life Sciences Holdings' Pretax Margin % too high?
Panacea Life Sciences Holdings' current Pretax Margin % is -368.00%. Based on the distribution chart, Panacea Life Sciences Holdings ranks #12 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Panacea Life Sciences Holdings' Pretax Margin % compare to NPHC and OWPC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #12 out of 955 companies for Pretax Margin %. This places Panacea Life Sciences Holdings in the top 1% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Panacea Life Sciences Holdings and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panacea Life Sciences Holdings's current Pretax Margin % is -368.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Pretax Margin % of -368.00%. The current Pretax Margin % is -368.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Pretax Margin % is -368.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Panacea Life Sciences Holdings Business Description
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSH has been successfully added to your 